Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Home - The Pharma Times | Pharma & Health Care News Portal
Tuesday, April 23, 2024

Philippines first country to grant permit for use of Sepsivac for...

Ahmedabad, September 21, 2021: The Philippines has become the first country to grant the emergency permit for use of Sepsivac, developed by Ahmedabad-based Cadila...

Coronavirus Diagnostics Market to Witness Robust Growth – TechSci Research

Surging cases of COVID-19 to drive global coronavirus diagnostics market New Delhi, April 29, 2020: According to TechSci Research report, “Global Coronavirus Diagnostics Market By...

Biotechnology

ESDS launches AA+ Covid 19 testing solution that indicates disease in less than 5...

Nashik,  May 20, 2020: One of India’s leading IT Solution company, ESDS Software Solution Pvt. Ltd. has come up with a rapid COVID-19 detection solution,...

Pharmaceutical Filtration Market Size Worth USD 43.96 Billion in 2030 | CAGR: 10.51%

New Delhi, August 18, 2023:  According to Adroit Market Research, the Global Pharmaceutical Filtration Market size was estimated at USD 19.99 billion and is expected to...

IT & Software Support

Wipro GE Healthcare keen to make diagnostics affordable to all

Wipro GE Healthcare is keen to invest in technologies that are affordable to all.

Terri Bresenhem, President and Chief Executive, GE Healthcare, told reporters here on Wednesday that the company has not only been expanding its presence in India for over two decades now, but investing at least 30 per cent more in recent years. “The investment is both in terms of manpower and strengthening our research and development facility,” she said.

INDIA MANUFACTURE

“We are striving to make healthcare affordable to all. While most medical equipment companies that have established their presence here import close to 80 per cent of their equipment, our import component is less. At GE Healthcare, we design and manufacture 30 per cent of the equipment in India. We have a strong research team, high quality thinkers and innovators here,” she added.

Appointments

HDFC Bank’s former CEO Aditya Puri joins pharma company’s board as chairperson

New Delhi, August 05, 2021: Aditya Puri, veteran banker and former chief executive of HDFC Bank, has joined the board of pharmaceutical company Solara as chairperson....

Awards

Takeda receives the Arogaya CIBioD Innovation and Enterprise Leadership Award

Takeda was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients The company recently...

Financial Results

Approvals

Clinical Trails

Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival...

Berlin, January 3, 2013 – Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase III trial of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer has met its primary endpoint of a statistically significant improvement in progression-free survival. The study, called DECISION, evaluated the efficacy and safety of Nexavar compared to placebo. The safety and tolerability were generally consistent with the known profile of Nexavar. Detailed efficacy and safety analysis from this study are expected to be presented at an upcoming medical meeting. Effective treatment options are urgently needed for patients with RAI-refractory differentiated thyroid cancer,” said Dimitris Voliotis, MD, Vice President, Global Clinical Development Oncology, Bayer HealthCare. “We are pleased that the results of this study demonstrate that Nexavar may provide a treatment option for these patients.

“swasthvayu” – India’s indigenous ventilator soon to start human clinical trials at Manipal Hospitals,...

New Delhi, July 23, 2020: The invention of ventilators has saved the lives of numerous patients, suffering from respiratory failure-a medical emergency characterized by...

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Optimizing Optic Health: Your Comprehensive Guide to Glaucoma Mastery

Dr. K Harshitha, Cataract and Glaucoma Surgeon, Maxivision Eye Hospitals, Hyderabad Glaucoma, often known as the "silent thief of sight," is a group of eye...

Beyond the Lens : Quality Assurance in Eye Hospitals

Dr. Deepa Shilpika , Sr. Medical Retina Specialist, Maxivision Super Speciality Eye Hospitals, Somajiguda, Hyderabad The field of ophthalmology has made tremendous strides in improving...

World Sight Day: Dr. Shroff’s Charity Eye Hospital and Standard Chartered Bank Restore Millions...

Vrindavan, October 12, 2023 :  On the occasion of World Sight Day, Dr. Shroff's Charity Eye Hospital, Daryaganj (SCEH) and Standard Chartered Bank (SCB) celebrated...

Product News

Media Partners

Spotlight

Investments

Packaging

Latest News

Innovations in Breast Reconstruction: 3D Printing, Advanced Techniques, and the Role of AI

Dr. Krithika Murugan, Oncosurgeon at HCG Cancer Hospitals, Bangalore.   Breast cancer affects millions of women worldwide, and for those who undergo mastectomy, breast reconstruction plays...

P&G Health commemorates Iron Deficiency Day with the launch of the ‘First Iron...

National, December 04, 2021: P&G Health, the health care division of Procter & Gamble (NYSE:PG), announced the launch of the 'First Iron Deficiency Diagnosis and...

Aster RV Hospital imparts Basic Life Support skills virtually

Bangalore,  May 23, 2020: Aster RV Hospital recently conducted an e-Basic Life Support skills program that is open for all. The pilot session was held...

Adoption of Public Health Strategies and Early Detection Key for Cancer Mitigation: Experts ...

Kochi, December 09, 2023: Cancer, being a devastating and complex disease, continues to pose a major global health challenge, impacting millions of people worldwide and...

Dental Care

The Global Dental and Diagnostics Surgical Equipment Market on The Rise

New Delhi, February 16, 2022: As of recent research, it has been predicted that the global dental and diagnostics surgical instrument industry is all...

Hospital Management

Drug Discovery & Development

North America to Dominate Drug Delivery Devices Market During Forecast Period – TechSci Research

Rising prevalence of chronic diseases is expected to drive the growth of global drug delivery devices market New Delhi, July 20, 2020: According to TechSci...

Suppliers

Technology

Mahindra Satyam builds digital modules for pharma, retail sectors

HYDERABAD, APRIL 4:  

Mahindra Satyam and Tech Mahindra have developed digitisation modules in the pharmaceutical, manufacturing, healthcare, energy and retail sectors.

Built around new technology, these modules showcase how a digitised pharma or manufacturing or a retail firm would look like and work.

What could a digitised enterprise do? It could predict your buying preferences or throw up a service offering based on your Internet behaviour. The way you predict faults in a power generator or predict a possible derailment of a train would all change as mobility, Internet and sensor technologies get aligned with the IT solutions.

Companies

Marketing

Our Partners

Machinery & Equipments